These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19901429)

  • 21. Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae.
    Kim SN; Jeong HS; Park SN; Kim HJ
    J Virol Methods; 2007 Jan; 139(1):24-30. PubMed ID: 17034867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum.
    Kohl TO; Hitzeroth II; Christensen ND; Rybicki EP
    BMC Biotechnol; 2007 Sep; 7():56. PubMed ID: 17850660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco.
    Lenzi P; Scotti N; Alagna F; Tornesello ML; Pompa A; Vitale A; De Stradis A; Monti L; Grillo S; Buonaguro FM; Maliga P; Cardi T
    Transgenic Res; 2008 Dec; 17(6):1091-102. PubMed ID: 18491213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of anti-HPV11-L1 antibodies in immune sera from patients suffering from recurrent respiratory papillomatosis using ELISA.
    Durzyńska J; Błazejewska P; Szydłowski J; Goździcka-Józefiak A
    Viral Immunol; 2010 Aug; 23(4):415-23. PubMed ID: 20712486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.
    Touze A; El Mehdaoui S; Sizaret PY; Mougin C; Muñoz N; Coursaget P
    J Clin Microbiol; 1998 Jul; 36(7):2046-51. PubMed ID: 9650960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viable adenovirus vaccine prototypes: high-level production of a papillomavirus capsid antigen from the major late transcriptional unit.
    Berg M; Difatta J; Hoiczyk E; Schlegel R; Ketner G
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4590-5. PubMed ID: 15767581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunogenicity study of HPV 6b virus-like particles].
    Liu Y; Liu X; Frazer IH
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):587-9. PubMed ID: 12133476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficiency of HPV 16 L1/E7 DNA immunization: influence of cellular localization and capsid assembly.
    Kuck D; Leder C; Kern A; Müller M; Piuko K; Gissmann L; Kleinschmidt JA
    Vaccine; 2006 Apr; 24(15):2952-65. PubMed ID: 16414157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic.
    Fernández-San Millán A; Ortigosa SM; Hervás-Stubbs S; Corral-Martínez P; Seguí-Simarro JM; Gaétan J; Coursaget P; Veramendi J
    Plant Biotechnol J; 2008 Jun; 6(5):427-41. PubMed ID: 18422886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the size distributions and immunogenicity of human papillomavirus type 16 L1 virus-like particles produced in insect and yeast cells.
    Kim HJ; Cho SY; Park MH; Kim HJ
    Arch Pharm Res; 2018 May; 41(5):544-553. PubMed ID: 29637494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach.
    Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA
    Virol J; 2015 Sep; 12():140. PubMed ID: 26362430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity.
    Schädlich L; Senger T; Kirschning CJ; Müller M; Gissmann L
    Vaccine; 2009 Mar; 27(10):1511-22. PubMed ID: 19174177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The concentration of carbon source in the medium affects the quality of virus-like particles of human papillomavirus type 16 produced in Saccharomyces cerevisiae.
    Kim HJ; Jin Y; Kim HJ
    PLoS One; 2014; 9(4):e94467. PubMed ID: 24714383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Codon optimization of the human papillomavirus type 58 L1 gene enhances the expression of soluble L1 protein in Saccharomyces cerevisiae.
    Kim HJ; Kwag HL; Kim HJ
    Biotechnol Lett; 2013 Mar; 35(3):413-21. PubMed ID: 23183918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient expression of Human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector.
    Varsani A; Williamson AL; Stewart D; Rybicki EP
    Virus Res; 2006 Sep; 120(1-2):91-6. PubMed ID: 16530873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe.
    Sasagawa T; Pushko P; Steers G; Gschmeissner SE; Hajibagheri MA; Finch J; Crawford L; Tommasino M
    Virology; 1995 Jan; 206(1):126-35. PubMed ID: 7831768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children.
    Marais DJ; Sampson CC; Urban MI; Sitas F; Wiliamson AL
    J Med Virol; 2007 Sep; 79(9):1370-4. PubMed ID: 17607783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
    Pinto LA; Viscidi R; Harro CD; Kemp TJ; García-Piñeres AJ; Trivett M; Demuth F; Lowy DR; Schiller JT; Berzofsky JA; Hildesheim A
    Virology; 2006 Sep; 353(2):451-62. PubMed ID: 16863657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of bead-based immunoassay to quantify neutralizing antibody for human papillomavirus 16 and 18.
    Liu HB; Chaturvedi PK; Battogtokh G; Bang HJ; Kim IW; Kim YW; Park KS; Ahn WS
    Mol Biotechnol; 2013 Jun; 54(2):361-70. PubMed ID: 22669586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation.
    de Witte L; Zoughlami Y; Aengeneyndt B; David G; van Kooyk Y; Gissmann L; Geijtenbeek TB
    Immunobiology; 2007; 212(9-10):679-91. PubMed ID: 18086370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.